News
Men with particularly aggressive prostate cancers can be treated more effectively by combining an existing targeted medicine, abiraterone, with a new experimental drug to block two of cancer’s growth signals at once, a major new trial has shown.
The Royal Marsden’s Sarcoma Unit is working with specialist centres around the world to improve the treatment of these rare cancers.
To accelerate research and improve patient outcomes, the world’s first centre for recurrent head and neck cancer has been launched at The Royal Marsden NHS Foundation Trust thanks to Royal Marsden Cancer Charity funding.
A new drug could become the first ever targeted brain cancer treatment, with encouraging early results from a phase 1 trial suggesting it could treat some patients with advanced disease.
There are around 3,200 new cases of cervical cancer in the UK every year and screening offers the greatest protection against cervical cancer with smear tests preventing 75% of cervical cancers.
This Loneliness Awareness Week (14-18 June), The Royal Marsden NHS Foundation Trust announced it has launched a telephone support service for cancer patients experiencing isolation.
Two new treatment options using immunotherapy for patients with advanced oesophageal cancer have shown significantly improved long-term survival, according to a study conducted at The Royal Marsden NHS Foundation Trust.
The Royal Marsden Private Care won two awards for our services at the virtual LaingBuisson Awards 2020, for Private Public Partnership and Best Hospital.
The Royal Marsden NHS Foundation Trust has donated over 200 pieces of IT equipment to local schools in Sutton to support children and young people’s learning through the COVID-19 pandemic.